Laura M Timmerman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Prognostic Factors

Immune Response

Ejection Fraction

Cell Proliferation

Top Venues

Cancer immunology, immunotherapy : CII

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Laura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, Rik J Verheijden, Karlijn P M Suijkerbuijk, Linde Meyaard, Michiel M van der Vlist, null null
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Michiel M van der Vlist, M Ines Pascoal Ramos, Lucas L van den Hoogen, Sanne Hiddingh, Laura M Timmerman, Titus A P de Hond, Ellen D Kaan, Maarten van der Kroef, Robert Jan Lebbink, Florence M A Peters, William Khoury-Hanold, Ruth Fritsch-Stork, Timothy R D J Radstake, Linde Meyaard
Signaling by the inhibitory receptor CD200R is rewired by type I interferon. Science signaling 14 (704) (2021)
Laura M Timmerman, J Fréderique de Graaf, Nikolaos Satravelas, Çan Kesmir, Linde Meyaard, Michiel van der Vlist
Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory function. PloS one 16 (3) (2021)